| 1. Guo Xiying, Lei Min, Ma Guandi, Ouyang Changhan, Yang Xiaosong, Liu Chao, Chen Qingjie, Liu Xiufen. (2023) Schisandrin A Alleviates Spatial Learning and Memory Impairment in Diabetic Rats by Inhibiting Inflammatory Response and Through Modulation of the PI3K/AKT Pathway. MOLECULAR NEUROBIOLOGY, [PMID:37910285] [10.1007/s12035-023-03725-w] |
| 2. Guangxu Cao, Shuang Li, Hezhan Shi, Peidi Yin, Jialing Chen, Huifeng Li, Ying Zhong, Li-Ting Diao, Bin Du. (2019) Schisandrin B attenuates renal fibrosis via miR-30e-mediated inhibition of EMT. TOXICOLOGY AND APPLIED PHARMACOLOGY, [PMID:31697999] [10.1016/j.taap.2019.114769] |
| 3. Cong Liu, Yun-Feng Cao, Zhong-Ze Fang, Yan-Yan Zhang, Cui-Min Hu, Xiao-Yu Sun, Ting Huang, Jia Zeng, Xu-Ran Fan, Mo Hong. (2012) Strong inhibition of deoxyschizandrin and schisantherin A toward UDP-glucuronosyltransferase (UGT) 1A3 indicating UGT inhibition-based herb–drug interaction. FITOTERAPIA, [PMID:23339253] [10.1016/j.fitote.2012.08.004] |
| 4. Zhao Zijia, Gao Yan, Yuan Min, Ye Cai, Guo Yingxue, Zhao Yanli, Li Jinlian, Cui Jiwen, Dong Tianwei, Wu Dongmei. (2024) Application Prospects of Schisandra chinensis Fruit Post-Distillation Residues in Anti-Photoaging Products: Enhancing Anti-Photoaging Through Lignans Conversion. Waste and Biomass Valorization, [PMID:] [10.1007/s12649-024-02846-0] |
| 5. Zhang Jinpeng, Cui Xinyuan, Zhao Shuo, Chang Zenghui, Zhang Junshuo, Chen Yufeng, Liu Jiale, Sun Guohao, Wang Yiyuan, Liu Yuanyuan. (2024) Establishment of a pharmacokinetics and pharmacodynamics model of Schisandra lignans against hippocampal neurotransmitters in AD rats based on microdi-alysis liquid chromatography-mass spectrometry. Frontiers in Pharmacology, [PMID:38529184] [10.3389/fphar.2024.1342121] |
| 6. Jiaming Yuan, Jincai Wang, Zhixu Chen, Yuexiang Chang, Litong Chen, Zhizeng Gao, Jacques Crommen, Tingting Zhang, Zhengjin Jiang. (2024) Establishment of an at-line nanofractionation-based screening platform by coupling HPLC-MS/MS with high-throughput fluorescence polarization bioassay for natural SARS-CoV-2 fusion inhibitors. JOURNAL OF CHROMATOGRAPHY A, [PMID:38797137] [10.1016/j.chroma.2024.464986] |
| 7. Pengyu Wang, Qing Lan, Qi Huang, Ruyi Zhang, Shuo Zhang, Leiming Yang, Yan Song, Tong Wang, Guandi Ma, Xiufen Liu, Xiying Guo, Youzhi Zhang, Chao Liu. (2024) Schisandrin A Attenuates Diabetic Nephropathy via EGFR/AKT/GSK3β Signaling Pathway Based on Network Pharmacology and Experimental Validation. Biology-Basel, 13 (8): (597). [PMID:39194535] [10.3390/biology13080597] |
| 8. Tian-Xiu Qiu, Lei Liu, Huan Wang, Yang Hu, Jiong Chen. (2024) Schisandrin A: a sustainable antiviral and immunomodulatory agent against spring viraemia of carp virus in aquaculture. FISH & SHELLFISH IMMUNOLOGY, [PMID:39306214] [10.1016/j.fsi.2024.109914] |
| 9. Guandi Ma, Min Lei, Shuang Guo, Yuqing Zhang, Yixuan Sun, Huimin Ji, Changhan Ouyang, Xiaosong Yang, Youzhi Zhang, Xiufen Liu, Baoqing Zhao, Xiying Guo. (2025) Schisandrin A ameliorates the diabetes-associated memory impairment by alleviating inflammation and ferroptosis: Schisandrin A ameliorates diabetes-associated memory impairment. ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 57 (10): (1647). [PMID:40589410] [10.3724/abbs.2025070] |
D1911039